Citation: | RAO Min-jie, LI Yi-nan, ZHANG Gong-heng, YUAN Xiao-jun, GAN Xin-rong, XU Wen-hua, CAO Sheng-sheng. Effect of zoledronic acid combined with percutaneous vertebroplasty on osteoporotic compression fractures in the elderly patients[J]. Chinese Journal of General Practice, 2021, 19(3): 383-386. doi: 10.16766/j.cnki.issn.1674-4152.001816 |
[1] |
ZHU Y, CHENG J, YIN J, et al. Therapeutic effect of kyphoplasty and balloon vertebroplasty on osteoporotic vertebral compression fracture: a systematic review and meta-analysis of randomized controlled trials[J]. Medicine, 2019, 98(45): e17810. doi: 10.1097/MD.0000000000017810
|
[2] |
SUN X, LIU X, WANG J, et al. The effect of early limited activity after bipedicular percutaneous vertebroplasty to treat acute painful osteoporotic vertebral compression fractures[J]. Pain Phy, 2020, 23(1): E31-E40. http://www.researchgate.net/publication/339067118_The_Effect_of_Early_Limited_Activity_after_Bipedicular_Percutaneous_Vertebroplasty_to_Treat_Acute_Painful_Osteoporotic_Vertebral_Compression_Fractures
|
[3] |
南运东. 唑来膦酸联合钙剂、阿法骨化醇防治老年骨质疏松脊柱压缩骨折患者PVP术后再骨折[J]. 颈腰痛杂志, 2019, 40(4): 553-554. doi: 10.3969/j.issn.1005-7234.2019.04.042
|
[4] |
BUCHBINDER R, JOHNSTON R V, RISCHIN K J, et al. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture[J]. Cochrane Database Syst Rev, 2018, 11(11): CD006349.
|
[5] |
石晨, 程安源. PKP联合唑来膦酸治疗骨质疏松性椎体压缩骨折的疗效分析[J]. 中国骨与关节损伤杂志, 2019, 34(7): 709-711. https://www.cnki.com.cn/Article/CJFDTOTAL-GGJS201907011.htm
|
[6] |
VISWANNATHAN M, REDDY S, BERKMAN N, et al. Screening to prevent osteoporotic fractures: an evidence review for the U.S. preventive services task force[J]. Rockville, 2018, 15(6): 35-39. http://www.ncbi.nlm.nih.gov/pubmed/29946734
|
[7] |
李正, 付军. 唑来膦酸和特立帕肽对预防椎体成形术后再发骨折的疗效比较[J]. 中国骨质疏松杂志, 2019, 25(7): 1002-1005. doi: 10.3969/j.issn.1006-7108.2019.07.024
|
[8] |
ZHU J, ZHANG K, LUO K, et al. Mineralized collagen modified polymethyl methacrylate bone cement for osteoporotic compression vertebral fracture at 1-year follow-up[J]. Spine, 2019, 44(12): 827-838. doi: 10.1097/BRS.0000000000002971
|
[9] |
马建华, 王庆雷. 高粘度骨水泥对不同程度骨质疏松性椎体压缩性骨折经皮椎体成形术的疗效影响及其弥散分析[J]. 中国基层医药, 2018, 25(21): 2721-2725. doi: 10.3760/cma.j.issn.1008-6706.2018.21.001
|
[10] |
WANG F, WANG L F, MIAO D C, et al. Which one is more effective for the treatment of very severe osteoporotic vertebral compression fractures: PVP or PKP?[J]. J Pain Res, 2018, 11(6): 2625-2631. http://www.ncbi.nlm.nih.gov/pubmed/30464581
|
[11] |
ISAWA M, KARAKAWA A, SAKAI N, et al. Biological effects of anti-RANKL antibody and zoledronic acid on growth and tooth eruption in growing mice[J]. Sci Rep, 2019, 9(1): 19895. doi: 10.1038/s41598-019-56151-1
|
[12] |
钟杰林, 蔡迎, 金成浩, 等. 唑来膦酸对老年女性骨质疏松性椎体压缩性骨折的疗效分析[J]. 中国中西医结合外科杂志, 2019, 25(3): 331-336. doi: 10.3969/j.issn.1007-6948.2019.03.017
|
[13] |
马晓勇, 高飞, 万英辉, 等. 绝经后骨质疏松性骨折治疗与再骨折的关系研究[J]. 河北医药, 2020, 42(2): 261-264. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ202002025.htm
|
[14] |
AGARWALA S, VIJAYVARGIVA M. Single dose therapy of zoledronic acid for the treatment of transient osteoporosis of hip[J]. Ann Rehabil Med, 2019, 43(3): 314-320. doi: 10.5535/arm.2019.43.3.314
|
[15] |
BAUER D C. Review: long-term alendronate or zoledronic acid reduces fractures in postmenopausal women with osteoporosis[J]. Ann Intern Med, 2019, 171(4): JC22. doi: 10.7326/ACPJ201908200-022
|
[16] |
张世浩, 苏菲, 王洪, 等. 唑来膦酸与阿仑膦酸钠预防PKP术后再骨折的效果分析[J]. 中国骨与关节损伤杂志, 2019, 34(11): 1125-1127. doi: 10.7531/j.issn.1672-9935.2019.11.002
|
[17] |
PFLIMLIN A, GOURNAY A, DELABRIÈRE I, et al. Secondary prevention of osteoporotic fractures: evaluation of the lille university hospital's fracture liaison service between January 2016 and January 2018[J]. Osteoporos Int, 2019, 30(9): 1779-1788. doi: 10.1007/s00198-019-05036-0
|
[18] |
赵成毅, 李青, 梁道臣, 等. 椎体成形术后应用唑来膦酸联合维生素K2治疗老年性椎体压缩骨折[J]. 中华关节外科杂志(电子版), 2018, 12(3): 433-437. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGJ201803025.htm
|
[19] |
HAN D, LONG A, WANG J, et al. Effect of cervus and cucumis polypeptide combined with zoledronic acid on bone metabolic biochemical markers in glucocorticoids-induced osteoporosis patients[J]. Saudi J Biol Sci, 2019, 26(5): 1027-1031. doi: 10.1016/j.sjbs.2019.04.010
|
[20] |
WONG S P Y, MOK C C. Update on symptomatic treatment of acute vertebral compression fracture[J]. J Clin Rhe, 2019, 19(2): 47-52. doi: 10.1142/S2661341719300039
|
[21] |
HOSOGANE N, NOJIRI K, SUZUKI S, et al. Surgical treatment of osteoporotic vertebral fracture with neurological deficit-a nationwide multicenter study in Japan[J]. Spine Surg Relat Res, 2019, 3(4): 361-367. doi: 10.22603/ssrr.2019-0004
|
[22] |
LEE B G, CHOI J H, KIM D Y, et al. Risk factors for newly developed osteoporotic vertebral compression fractures following treatment for osteoporotic vertebral compression fractures[J]. Spine J, 2019, 19(2): 301-305. doi: 10.1016/j.spinee.2018.06.347
|